Introduction
The insulin response to food ingestion is determined by the direct actions of glucose and certain amino acids on the pancreatic B-cell together with indirect actions generated through activation of both hormonal and neural arms of the enteroinsular axis [ 1-31. These signals are normally integrated at the level of the pancreatic B-cell such that insulin is secreted to appropriately regulate nutrient metabolism and glucose homeostasis. In non-insulindependent diabetes mellitus (NIDDM), defects in the mechanisms that regulate insulin secretion make a major contribution to the glucose intolerance and metabolic disarray associated with the disease [ 4-61. Possible molecular mechanisms underlying pancreatic B-cell dysfunction in NIDDM include site-specific defects in the stimulus-secretion coupling pathway and changes in B-cell function consequent to alterations in external influences on the B-cell. The participation and interaction of the various pathways to disturbances of insulin secretion in NIDDM are considered below in the framework of our present understanding of the regulation of B-cell function and stimulussecretion coupling.
Susceptible points in B-cell stimulussecretion coupling
Glucose insensitivity of the pancreatic B-cell lies at the heart of defective insulin secretion in NIDDM [4-61. Glucose is the principal regulator of B-cell function and also amplifies the insulinotropic actions of all other secretogogues, including enteroAbbreviations used: NIL)L)M, non-insulin-dependent diabetes mellitus; [CaL+] ,, cytoplasmic CaL+ concentration; K+-ATI', ATP-sensitive K + channel. 'To whom correspondence should be addressed. insular hormones and neurotransmitters [7] . It follows that each site in the series of steps linking B-cell glucose recognition to insulin discharge represents a potential influential lesion that might result in defective insulin secretion, characteristic of NIDDM. The normal secretory pathway induced by glucose starts with transport of the sugar into the B-cell by the GLUT2 glucose transporter (for comprehensive coverage of the pathway see . Phosphorylation of glucose, by glucokinase, and subsequent metabolism leads to the generation of ATP and increase of the ATPIADP ratio. This results in closure of ATP-sensitive K + channels (K+-ATP channels) in the B-cell membrane, depolarization, opening of voltage-dependent Ca2+ channels and CaZ+ influx. The resulting increase in cytoplasmic Ca2+ concentration ([Ca2+Ii) then triggers the secretory machinery, culminating in the discharge of insulin by exocytosis. Ca2+ also activates enzymes such as adenylate cyclase (with generation of cyclic AMP) and phospholipase C (with production of inositol 1,4,5-trisphosphate and diacylglycerol, which activates protein kinase C) that serve both to displace Ca2+ from intracellular stores and to sensitize the secretory machinery to [Ca2+Ii [ 101. Hormonal and neural elements of the enteroinsular axis potentiate the insulin secretory process through interactions with membrane receptors that are also linked to activation of adenylate cyclase or phospholipase C [7] .
Site-specific defects in 8-cell dysfunction
Site-specific defects in the pancreatic B-cell have been uncovered in studies evaluating mechanisms of defective insulin secretion using islets isolated from various animal models of NIDDM [6] . Less
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certain is the extent to which such defects (summarized in Table 1 ) are primary genetic manifestations or secondary features acquired from abnormalities of the B-cell environment and external influences. A future search for mutations of key functional proteins in the B-cell secretory machinery will undoubtedly help to address this issue. These discussions have an important bearing on the debate, conducted elsewhere, on whether the primary defect in NIDDM is at the level of the B-cell rather than at the site of insulin action [4, 5, 121.
Insulin synthesis and trafficking
Point mutations of the insulin gene and other mutations which may affect the intracellular processing and trafficking of proinsulin have been observed in small numbers of human subjects [13] . Although the frequency of such mutations is low, mechanisms which potentially lead to the abnormal release of proinsulin from the B-cell are relevant to the hyperproinsulinaemia encountered in NIDDM.
Stimulus-secretion coupling
Abnormalities have been detected in NIDDM at almost all known stages of the pancreatic B-cell stimulus-secretion coupling pathway [6] . Brief consideration of the principal site-specific lesions contributing to defective insulin secretion in specific examples of NIDDM is given below. Mutations at this locus are not common in classical NIDDM [ 171. However, the apparent link between glucokinase activity and defective insulin secretion highlights the need for more detailed studies on possible changes in the activity of the enzyme in the diabetic B-cell.
GLUTZ glucose transporter
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Glucose-6-phosphatase (glucose cycle)
A high rate of glucose cycling (namely metabolism of glucose to glucose-6-phosphate and back to glucose) catalysed by glucokinase and glucose-6-phosphatase has been demonstrated in the islets of ob/ob mice, GK rats and rats treated with streptozotocin during the neonatal period [ 181. Consumption of one molecule of ATP for each molecule of glucose cycled might, by decreasing the ATP pool, interfere with the regulation of K+-ATP channels and contribute to defective insulin secretion.
Mitochondria1 FAD-glycerophosphate deh ydrogenose
Activation of mitochondria1 FAD-linked glycerophosphate dehydrogenase by [Ca2+Ii is proposed to optimize ATP generation from glucose in B-cells through preferential stimulation of oxidative, as opposed to total, glycolysis [19] . The enzyme appears therefore to serve an important role in the glucose-sensing function in the B-cell. Alterations of mitochondria1 FAD-linked glycerophosphate dehydrogenase activity have been described in various animal models of experimentally-induced and spontaneous NIDDM, including adult rats treated neonatally with streptozotocin, GK rats, fufu rats and C57BI,/KsJ db/db mice [20] .
Generation of ATP
Despite the key role of ATP generation and increase of ATP/ADP ratio in the closure of K+-ATP channels, few studies have actually addressed directly the link between defective insulin secretion and perturbations of ATP generation. One problem is undoubtedly the difficulty in monitoring functionally important changes of ATP specifically adjacent to K+-ATP channels. Nevertheless, a compromise in the generation of cellular ATP has been clearly shown to be associated with the glucose unresponsiveness of fetal rat pancreatic B-cells [21] .
K+-ATP channels
Early studies of pancreatic B-cell membrane potential and XhRb efflux, from preloaded islets of C57BL/KsJ db/db mice and diabetic Chinese hamsters, demonstrated an association between abnormalities in the regulation of K + permeability and defective insulin secretion [22-241. Cellattached and inside-out configurations of the patchclamp technique have been used recently to directly assess the regulation of K+-ATP channels in B-cells isolated from animal models. Studies using the neonatal-streptozotocin-treated rat model and GK rats indicate that the inhibitory effect of glucose on B-cell K+-ATP channels is impaired in NIDDM [25, 261. However, sensitivity of the channels to direct application of ATP using inside-out patches was intact. This suggests that glucose insensitivity of the K+-ATP channels in these models reflects impaired cellular ATP generation rather than a defect in the K+-ATP channel perse.
Regulation of [Co" 1, and contractile proteins Disturbances in the regulation of transmembrane Ca2+ fluxes and [Ca2+Ii represent a common feature associated with defective insulin secretion in animal models of NIDDM, including C57BL/KsJ db/db mice, Spiny mice and neonatal-streptozotocin-treated rats [6] . Abnormal regulation of [Ca2+Ii undoubtedly plays a major role in the defective stimulus-secretion of the B-cell in NIDDM. However, the extent to which such abnormalities reflect disturbances at earlier stages of the secretory process is uncertain. Site-specific lesions in voltagedependent Ca2+ channels, intracellular Ca2+ transport and the effects of Ca2+ on the exocytotic machinery remain to be established. Apparent disturbances in microtubules and microfilaments involved in exocytosis have been reported in diabetic Spiny mice and C57BIJKsJ db/db mice [27, 281.
Alterations of external input and B-cell dysfunction
NIDDM is associated with significant disturbances in the local environment of the €3-cell, including profound changes in the concentrations of nutrients and hormones with established effects on insulin secretion [4-61. As illustrated by specific examples given below, such alterations can undoubtedly contribute to B-cell dysfunction. In certain cases, most notably hyperglycaemia-induced glucose toxicity, alterations in external environment may actually lead to the production of site-specific defects in the €3-cell. 
Local modulators of secretion
Alterations of autonomic tone
The islet autonomic innervation plays a subtle and possibly important role in the fine-tuning of insulin secretion [3, 
B-cell hyperactivity
There is good evidence for a link between B-cell hyperactivity and defective insulin responses in some forms of experimental and spontaneous dia- 
Glucose toxicity
Studies in man and experimental animals, using potentially important considerations arise from these observations. First, species differences in susceptibility might be due to differences in endogenous protection against the mechanisms involved in mediation of glucose toxicity. Secondly, the apparent requirement for a genetically susceptible B-cell might imply that the deleterious effects of hyperglycaemia may become manifest by imposing additional functional strain on existing weakspots in the insulin secretory pathway of predisposed €3-cells.
Role of glycation in B-cell glucose toxicity
Despite compelling evidence that €3-cell glucose toxicity makes an important contribution to defective insulin secretion in established NIDDM, few studies have addressed the molecular mechanisms shown that detrimental effects of chronic exposure to hyperglycaemia on insulin secretory responsiveness are associated with a substantial glycation of intracellular proteins [49] . Since glycation can be expected to influence the function of key proteins in the R-cell secretory machinery, it is not unreasonable to propose that glycation of important regulatory proteins serves as a cardinal mediator of H-cell glucose toxicity. Furthermore, ongoing studies indicate that insulin is also a target for glycation in €?-cells exposed to hyperglycaemia and that glycation impairs insulin-mediated glucose disposal at peripheral tissues [SO, 511. In this respect, it appears that glycation of insulin in NIDDM provides a novel link in the vicious spiral that, by promoting insulin resistance, exacerbates hyperglycaemia and consequently H-cell dysfunction.
Conclusions
Pancreatic B-cell dysfunction in NIDDM represents the combined effects of site-specific defects in the 
Introduction
Nitric oxide (NO) appears to be an important mediator of the inflammatory attack against islet cells in autoimmune diabetes. amide protects against NO toxicity 1.21 and func-
